Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.
“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.
The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.
“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”
Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.
The Latest on: Drug-delivery nanoparticles
via Google News
The Latest on: Drug-delivery nanoparticles
- Nanotechnology Drug Delivery Market Share Current and Future Industry Trends, 2021-2026on June 18, 2021 at 12:44 am
According to our latest research, the global Nanotechnology Drug Delivery market size is estimated to be USD 8000.6 million in 2026 from USD 6153.4 million in 2020. The global Nanotechnology Drug ...
- Versatile Nanosponge Drug Delivery Platform Proves Effective in Inflamed Lungson June 17, 2021 at 5:00 am
Nanoengineers have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. The researchers filled the nanoparticles with ...
- Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungson June 16, 2021 at 11:35 am
In particular, cell membrane–coated nanoparticles have proven to be effective drug delivery systems owing to their extended circulation times and disease-homing capabilities (26–28). The targeting ...
- Genetically engineered nanoparticle delivers dexamethasone directly to inflamed lungson June 16, 2021 at 11:00 am
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a ...
- The Role of Nanoparticles for Drug Deliveryon June 15, 2021 at 1:46 am
In this interview, Mark Bumiller, Technology Manager at Entegris talks to News Medical Life Sciences about the role nanoparticles can play in drug delivery.
- Targeting cancer cells over healthy cells with nanoparticle shapeon June 10, 2021 at 1:25 am
(Nanowerk Spotlight) Researchers working on nanomedicine drug delivery have known for a few years now that the shape and geometry of nanoparticles can have a significant impact in dampening adverse ...
via Bing News